23 May 2013
Keywords: synergen, future, appears, rocky, after, antril, failure
Article | 25 July 1994
Synergen has stopped its follow-up trial of Antril (anakinra) for severe
sepsis, after an interim analysis of data showed a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 July 1994
22 May 2013
© 2013 thepharmaletter.com